Enorama Pharma AB (publ) (STO: ERMA)
4.810
-0.190 (-3.80%)
Aug 30, 2024, 4:53 PM CET
Enorama Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 41.75 | 47.53 | 46.41 | 64.1 | 76.26 | 73.68 | Upgrade
|
Cash & Short-Term Investments | 41.75 | 47.53 | 46.41 | 64.1 | 76.26 | 73.68 | Upgrade
|
Cash Growth | -44.77% | 2.43% | -27.61% | -15.94% | 3.50% | -7.38% | Upgrade
|
Accounts Receivable | 19.9 | 19.17 | 11.48 | 24.03 | 12.93 | 29.28 | Upgrade
|
Other Receivables | 6.67 | 3.5 | 3.64 | 1.92 | 2.44 | 3.59 | Upgrade
|
Receivables | 26.57 | 22.67 | 15.12 | 25.95 | 15.38 | 32.87 | Upgrade
|
Inventory | 0.29 | 0.36 | 0.31 | 0.55 | 1.05 | - | Upgrade
|
Prepaid Expenses | - | 2.9 | 3.4 | 3.51 | 3.68 | 1.88 | Upgrade
|
Other Current Assets | -0 | -0 | - | - | - | - | Upgrade
|
Total Current Assets | 68.6 | 73.47 | 65.23 | 94.11 | 96.37 | 108.42 | Upgrade
|
Property, Plant & Equipment | 10.41 | 6.45 | 9.09 | 11.47 | 8.92 | 1.89 | Upgrade
|
Goodwill | - | 84.84 | 84.84 | 84.84 | 23.43 | 23.43 | Upgrade
|
Other Intangible Assets | 128.62 | 21.83 | 24.26 | 26.72 | 4.59 | 5.4 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | - | 5.75 | Upgrade
|
Long-Term Deferred Charges | - | 26.08 | 29.8 | 23.93 | 19.65 | 13.59 | Upgrade
|
Other Long-Term Assets | - | -0 | - | - | - | - | Upgrade
|
Total Assets | 207.64 | 212.67 | 213.22 | 241.05 | 152.95 | 158.47 | Upgrade
|
Accounts Payable | - | 2.72 | 5.95 | 10.08 | 5.68 | 4.86 | Upgrade
|
Accrued Expenses | - | 8.45 | 5.08 | 26.55 | 12.28 | 12.82 | Upgrade
|
Current Portion of Leases | - | 8.47 | 11.74 | 1.67 | 1.13 | 1 | Upgrade
|
Current Unearned Revenue | - | 13.95 | 17.07 | - | 12.96 | 13.02 | Upgrade
|
Other Current Liabilities | 34.81 | 2.31 | 1.73 | 34.24 | 1.19 | 0.18 | Upgrade
|
Total Current Liabilities | 34.81 | 35.89 | 41.57 | 72.54 | 33.24 | 31.88 | Upgrade
|
Long-Term Leases | 21.9 | 13.46 | 20.99 | 5.93 | 5.67 | 0.07 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 4 | 4.36 | 5.62 | - | - | Upgrade
|
Other Long-Term Liabilities | - | -0 | - | 28.92 | - | 0.05 | Upgrade
|
Total Liabilities | 56.71 | 53.35 | 66.92 | 113 | 38.91 | 32.01 | Upgrade
|
Common Stock | 150.93 | 23.54 | 14.25 | 11.88 | 10.81 | 10.81 | Upgrade
|
Additional Paid-In Capital | - | 917.82 | 887.56 | 849.4 | 823.19 | 823.19 | Upgrade
|
Retained Earnings | - | -786.45 | -760.05 | -737.49 | -724.05 | -711.81 | Upgrade
|
Comprensive Income & Other | - | 4.41 | 4.53 | 4.27 | 4.1 | 4.28 | Upgrade
|
Shareholders' Equity | 150.93 | 159.32 | 146.3 | 128.05 | 114.04 | 126.47 | Upgrade
|
Total Liabilities & Equity | 207.64 | 212.67 | 213.22 | 241.05 | 152.95 | 158.47 | Upgrade
|
Total Debt | 21.9 | 21.93 | 32.73 | 7.6 | 6.8 | 1.07 | Upgrade
|
Net Cash (Debt) | 19.84 | 25.61 | 13.68 | 56.51 | 69.46 | 72.61 | Upgrade
|
Net Cash Growth | -61.09% | 87.19% | -75.79% | -18.65% | -4.33% | -8.72% | Upgrade
|
Net Cash Per Share | 0.30 | 0.39 | 0.33 | 1.56 | 1.93 | 2.01 | Upgrade
|
Filing Date Shares Outstanding | 77.38 | 77.38 | 46.43 | 39.6 | 36.02 | 36.02 | Upgrade
|
Total Common Shares Outstanding | 77.38 | 77.38 | 46.43 | 39.6 | 36.02 | 36.02 | Upgrade
|
Working Capital | 33.8 | 37.58 | 23.66 | 21.57 | 63.13 | 76.54 | Upgrade
|
Book Value Per Share | 1.95 | 2.06 | 3.15 | 3.23 | 3.17 | 3.51 | Upgrade
|
Tangible Book Value | 22.31 | 52.65 | 37.21 | 16.5 | 86.03 | 97.64 | Upgrade
|
Tangible Book Value Per Share | 0.29 | 0.68 | 0.80 | 0.42 | 2.39 | 2.71 | Upgrade
|
Machinery | - | 7.24 | 7.12 | 6.18 | 2.63 | 1.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.